Summary of Bliss scores and sensitivity to dinaciclib, navitoclax and combination treatment.

1<p>Synergy analysis after 18 hr treatment. vBliss: synergy (>0.1), additive (0.1–0.05). neutral (<0.05-0), antagonistic (<0).</p>2<p>Percent viability after 18 hour treatment with 100 nM dinaciclib, 1 µM navitoclax or the combination.</p>3<p>Information source. Cancer Cell Line Encyclopedia converted from log 2 to log10.</p><p>Summary of Bliss scores and sensitivity to dinaciclib, navitoclax and combination treatment.</p>